NL-OMON39222
Completed
Not Applicable
Fear acquisition and extinction mechanisms in relation to treatment outcome: a study in patients with anxiety disorders - Fear acquisition & extinction mechanisms in relation to treatment outcome
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anxiety disorder
- Sponsor
- niversiteit Utrecht
- Enrollment
- 310
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a. Patients with a lifetime diagnosis of the following disorders as a primary diagnosis: Panic disorder with or without agoraphobia, social anxiety disorder, specific phobia, generalized anxiety disorder, post\-traumatic stress disorder and obsessive compulsive disorder.
- •b. Males and females between 18 and 65 years old.
- •c. Command of the Dutch language (i.e. ability to understand procedures and questionnaires).
- •d. Normal or corrected normal vision.;The inclusion criteria for the healthy controls participating in conditioning task 1 are the same as described above, with the exception of criterium a.
Exclusion Criteria
- •a. Current comorbid severe psychiatric disorder in the past 6 months: i.e. severe major depressive disorder (BDI \* 30\), bipolar disorder, psychotic disorder.
- •b. Lifetime history of substance dependence, or substance abuse within the last three months.
- •c. Mental retardation (IQ \< 80\)
- •d. History of any physical disease which may confound the results of the study according to the investigator, like brain damage.
- •e. Hearing/ vision problems
- •f. Current use of antipsychotic medication;The inclusion criteria for the healthy controls participating in conditioning task 1 are the same as described above.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Dissecting the mechanisms of fear formation: a pharmacological study with healthy volunteerspost-traumatic stress disorderPTSD10002861NL-OMON38140Erasmus MC, Universitair Medisch Centrum Rotterdam120
Completed
Phase 4
Chronobiological aspects of fear extinction by d-cycloserine and valproic acidAnxiety disorderJPRN-UMIN000003833Department of Adult Mental Health, National Institute of Mental Health, National Center of Neurology and Psychiatry90
Not yet recruiting
Phase 2
Pharmacological enhancement of fear extinction in OCD; a randomized placebo controlled, double blind study.Obsessive Compulsive DisorderNL-OMON33819Academisch Medisch Centrum60
Completed
Not Applicable
Fear conditioning during specific conditions in antisocial adolescents: a neuroimaging study.10037173conduct disorder - antisocial behaviorNL-OMON39929Vrije Universiteit Medisch Centrum83
Not yet recruiting
Not Applicable
Association between movement related fear, neck disability and pain in patients with long standing neck pain.Health Condition 1: M999- Biomechanical lesion, unspecifiedCTRI/2020/08/027235Dipti Geete